Günter Wolf

17.1k total citations · 2 hit papers
359 papers, 12.3k citations indexed

About

Günter Wolf is a scholar working on Molecular Biology, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Günter Wolf has authored 359 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 88 papers in Nephrology and 71 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Günter Wolf's work include Chronic Kidney Disease and Diabetes (56 papers), Advanced Glycation End Products research (34 papers) and Renal Diseases and Glomerulopathies (34 papers). Günter Wolf is often cited by papers focused on Chronic Kidney Disease and Diabetes (56 papers), Advanced Glycation End Products research (34 papers) and Renal Diseases and Glomerulopathies (34 papers). Günter Wolf collaborates with scholars based in Germany, United States and Switzerland. Günter Wolf's co-authors include Fuad N. Ziyadeh, Christiane Rüster, Eric G. Neilson, Ivonne Loeffler, Sybille Franke, Rolf A.K. Stahl, Sheldon Chen, Ulrich Müller, Eberhard Ritz and Tzvetanka Bondeva and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Günter Wolf

342 papers receiving 12.0k citations

Hit Papers

Stimulation of collagen g... 1994 2026 2004 2015 1994 2009 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Günter Wolf 3.7k 3.5k 2.3k 1.9k 1.4k 359 12.3k
Barry I. Freedman 6.2k 1.7× 3.3k 0.9× 3.2k 1.4× 2.6k 1.4× 780 0.5× 420 16.3k
Gary E. Striker 3.0k 0.8× 2.2k 0.6× 2.6k 1.1× 1.4k 0.7× 2.9k 2.0× 150 13.5k
Yoshinari Yasuda 4.1k 1.1× 1.8k 0.5× 1.5k 0.7× 2.3k 1.2× 1.0k 0.7× 152 10.6k
Hidenori Koyama 1.8k 0.5× 5.9k 1.7× 1.8k 0.8× 2.3k 1.2× 1.0k 0.7× 414 15.1k
Juan F. Navarro‐González 3.8k 1.0× 1.7k 0.5× 1.7k 0.7× 871 0.5× 1.0k 0.7× 212 8.1k
Lise Tarnow 2.9k 0.8× 2.1k 0.6× 5.2k 2.3× 4.1k 2.2× 1.2k 0.8× 279 12.1k
Donald W. Bowden 3.2k 0.9× 4.1k 1.2× 2.7k 1.2× 2.0k 1.1× 387 0.3× 359 14.7k
Reiko Inagi 2.7k 0.7× 2.9k 0.8× 1.2k 0.5× 660 0.3× 2.1k 1.5× 194 10.1k
Carla Zoja 4.8k 1.3× 3.4k 1.0× 1.3k 0.6× 2.4k 1.3× 501 0.3× 192 13.3k
Marta Ruiz‐Ortega 4.7k 1.3× 6.9k 2.0× 2.2k 1.0× 3.8k 2.0× 779 0.5× 265 18.2k

Countries citing papers authored by Günter Wolf

Since Specialization
Citations

This map shows the geographic impact of Günter Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Günter Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Günter Wolf more than expected).

Fields of papers citing papers by Günter Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Günter Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Günter Wolf. The network helps show where Günter Wolf may publish in the future.

Co-authorship network of co-authors of Günter Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Günter Wolf. A scholar is included among the top collaborators of Günter Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Günter Wolf. Günter Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heiling, Bianka, Thomas Lehmann, N Müller, et al.. (2025). What does nerve ultrasound contribute to the evaluation of diabetic polyneuropathy over time? A prospective follow-up observational study of people with type 2 diabetes. Diabetes Research and Clinical Practice. 222. 112115–112115.
2.
Gaßler, Nikolaus, et al.. (2024). The Role of Collagen VIII in the Aging Mouse Kidney. International Journal of Molecular Sciences. 25(9). 4805–4805. 1 indexed citations
3.
Wolf, Günter, et al.. (2024). Role of Epigenetic Changes in the Pathophysiology of Diabetic Kidney Disease. SHILAP Revista de lepidopterología. 4(1). 211–226. 1 indexed citations
5.
Pfeil, Alexander, Philipp Klemm, Axel J. Hueber, et al.. (2023). Enhancing student understanding of rheumatic disease pathologies through augmented reality: findings from a multicentre trial. Lara D. Veeken. 63(7). 1949–1956. 1 indexed citations
6.
Loeffler, Ivonne, et al.. (2023). The Role of Hypoxia on the Trimethylation of H3K27 in Podocytes. Biomedicines. 11(9). 2475–2475. 1 indexed citations
7.
Herrmann, Karl‐Heinz, Anja Urbach, Cornelius Lemke, et al.. (2023). Targeted Disruption of the MORG1 Gene in Mice Causes Embryonic Resorption in Early Phase of Development. Biomolecules. 13(7). 1037–1037. 1 indexed citations
8.
Gerdes, Christian, N Müller, Günter Wolf, & Martin Busch. (2023). Nephroprotective Properties of Antidiabetic Drugs. Journal of Clinical Medicine. 12(10). 3377–3377. 13 indexed citations
9.
Lehmann, Thomas, et al.. (2023). Metabolic Control, Diabetic Complications and Drug Therapy in a Cohort of Patients with Type 1 and Type 2 Diabetes in Secondary and Tertiary Care between 2004 and 2019. International Journal of Environmental Research and Public Health. 20(3). 2631–2631. 2 indexed citations
10.
Nadal, Jennifer, Barbara Bärthlein, Heike Meiselbach, et al.. (2023). Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease—prospective data from the German Chronic Kidney Disease cohort. Clinical Kidney Journal. 16(11). 2032–2040. 5 indexed citations
12.
Oelzner, Peter, Ulf Teichgräber, Marcus Franz, et al.. (2023). Diagnosing lung involvement in inflammatory rheumatic diseases—Where do we currently stand?. Frontiers in Medicine. 9. 1101448–1101448. 6 indexed citations
13.
Mirna, Moritz, Albert Topf, Bernhard Wernly, et al.. (2020). Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study. Journal of Clinical Medicine. 9(3). 886–886. 19 indexed citations
14.
Bondeva, Tzvetanka, et al.. (2020). Ramipril pretreatment worsened renal injury and survival despite a reduction in renal inflammation in experimentally induced sepsis in mice. Journal of the Renin-Angiotensin-Aldosterone System. 21(2). 2691647817–2691647817. 3 indexed citations
15.
Kloos, C, et al.. (2020). Complementary and alternative medicine is positively associated with religiousness/spirituality. Journal of Complementary and Integrative Medicine. 18(1). 185–192. 5 indexed citations
16.
Drinda, Stefan, et al.. (2017). AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis. Complementary Medicine Research. 25(3). 167–172. 9 indexed citations
17.
Pfeil, Alexander, Peter Oelzner, Andreas Hansch, et al.. (2013). Joint damage in rheumatoid arthritis: assessment of a new scoring method. Arthritis Research & Therapy. 15(1). R27–R27. 18 indexed citations
18.
Frahm, Christiane, et al.. (2012). Morg1+/− heterozygous mice are protected from experimentally induced focal cerebral ischemia. Brain Research. 1482. 22–31. 12 indexed citations
19.
Kirchhoff, F., Christian F. Krebs, Catherine Meyer‐Schwesinger, et al.. (2007). Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II. Kidney International. 73(5). 643–650. 42 indexed citations
20.
Panzer, Ulf, André Schneider, Youfei Guan, et al.. (2002). Effects of different PPARγ-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis. Kidney International. 62(2). 455–464. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026